All articles tagged with #muscle atrophy
An international study using mice aboard JAXA's centrifuge simulated Martian gravity (0.33 g, 0.67 g, and 1 g) and found that 0.33 g mitigates spaceflight-induced muscle loss while 0.67 g fully preserves muscle performance, suggesting partial gravity during Mars missions could help maintain astronauts' muscle health; researchers also identified 11 metabolites as potential biomarkers of physiological adaptation.
Researchers have developed compounds that mimic the effects of exercise in rodent cells, potentially offering new treatments for muscle atrophy, heart failure, and neurodegenerative diseases. The compounds activate estrogen-related receptors (ERRs) and have shown promise in enhancing muscle cells' metabolism and growth, as well as improving muscle performance in animal studies. The research, presented at ACS Spring 2024, suggests that these compounds could have applications in treating metabolic disorders, conditions linked to mitochondrial dysfunction, and neurodegenerative diseases.
Scientists are developing a pill that mimics the benefits of exercise, potentially offering a solution for those unable to work out due to medical conditions or time constraints. The compound SLU-PP-332 and its new iterations activate proteins responsible for metabolic pathways and have shown promising results in rodents, including improved endurance and muscle function. The research team aims to create a safe and potent drug that could be used in humans within the next five years, with potential applications for treating muscle atrophy, obesity, and neurodegenerative diseases.
Scientists have developed a compound called SLU-PP-332 that mimics the physical benefits of exercise in rodents, with the potential to treat muscle atrophy and improve physical fitness in humans, especially those with serious ailments. The compound activates a group of proteins responsible for metabolic pathways in high-energy-demand tissues, and new patentable molecules have shown even stronger effects in mimicking exercise. The research team aims to develop a pill form of the drug for human use, potentially offering benefits such as weight loss, improved insulin sensitivity, and enhanced exercise endurance.
Researchers are developing compounds that mimic the benefits of physical exercise, potentially offering new treatments for muscle atrophy, heart failure, and neurodegenerative diseases. The compound SLU-PP-332 and its derivatives activate key proteins involved in exercise-induced muscle growth and metabolism, and could provide an alternative for those unable to engage in regular physical activity. The team's work, supported by NIH grants, marks a significant step towards creating medications that replicate exercise's physiological effects.
Researchers have discovered that the common diabetes drug, Metformin, can prevent muscle atrophy and fibrosis, potentially aiding in faster recovery from injury in the elderly. The drug targets senescent cells, which affect muscle function, and its benefits were observed in a study with older adults during periods of muscle disuse and recovery. This finding opens up new possibilities for using Metformin to improve muscle recovery in aging individuals.